Skip to content
Recall Observatory FDA recall evidence

Drug product

Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37

D-0996-2019

February 21, 2019

Class III

Product summary

Firm
Lannett Company Inc.
Event
Event 82144
Status
Terminated
Classification
Class III
Quantity
14,448 bottles
Official record key
drug-enforcement:D-0996-2019

Official wording

Reason: Failed Dissolution Specifications

Code information: Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021

Distribution pattern: Nationwide, including Puerto Rico.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications